Phosphorothioate oligodeoxynucleotides produce splenomegaly and mononuclear
cell infiltrates in multiple organs in mice after repeated i.v. administra
tion. Several phosphorothioate oligodeoxynucleotides were studied to better
understand the basis of immunostimulatory properties of these molecules in
mice and to study the effects of chemically modified oligonucleotides. Che
mical modifications examined included 5-methyl cytosine and 2'-methoxyethox
y substituents. Male mice (six per group) were treated with oligonucleotide
concentrations of 0, 2, 10, or 50 mg/kg by i.v. injection every other day
for 14 days. Immune stimulation was assessed 24 h after the last dose by me
asuring spleen weight, or histologic and immunohistochemical examination of
liver and kidney. Immune stimulation was dose-dependent for the phosphorot
hioate oligodeoxynucleotides studied, but potency varied as a function of s
equence. Results from this study reveal that there is a close correlation b
etween the extent of splenomegaly and other evidence of immune stimulation,
such as the severity of cell infiltrates in liver and kidney in mice. Immu
nohistochemical analysis indicated that cell infiltrates in liver and kidne
y were primarily mononuclear cells associated with increased expression of
the endothelial-leukocyte cellular adhesion molecule intracellular adhesion
molecule-1 and the cytokine interleukin-6. Immune stimulation was markedly
decreased with oligonucleotides containing the 5-methyl cytosine and furth
er decreased by 2'-methoxyethoxy modifications. Administration of these mod
ified oligonucleotides to mice did not produce splenomegaly even at the 50-
mg/kg dose, and only produced minimal cell infiltrates despite the presence
of comparable or greater tissue oligonucleotide concentrations. Thus, chem
ical modifications appeared to increase the tolerability profile for these
compounds that are representative of the second generation of antisense oli
gonucleotides.